Request an Appointment Online, or call us at (888) 824-0200

The University of Chicago Medicine - Comer Children's Hospital

Why Choose Us for Pediatric Sarcoma Care?

Experience and Expertise

Sarcomas are relatively uncommon cancers. As such, some medical providers are not that familiar with the steps needed to make the correct diagnosis and outline the best treatment plan. Sarcomas are also complex. Their treatment must be comprehensive and multidimensional. We have treated children with sarcomas from throughout the Midwest and elsewhere for more than 30 years. Our pediatric oncologists, surgical oncologists (including orthopaedic surgeons), and radiation oncologists are specialists in addressing the many different types of sarcomas that can affect children and young adults of all ages. And our pathologists have the knowledge and experience to recognize even the most unusual forms of this type of cancer.

Diagnostics: The Right Diagnosis Guides the Right Treatment

Many general pediatricians, pathologists and even oncologists never encounter a rare sarcoma in their practice. Here, University of Chicago pediatric oncologists and pathologists have extensive experience with sarcomas, so they're able to recognize when a child should be tested for the disease. Sophisticated molecular testing enables our pathologists and physicians to identify the specific type of sarcoma and its key characteristics. This information is invaluable for determining the most effective treatment for each child's case.

A Full Range of Treatment Options

Treatment of sarcomas is very different than treatment of more common childhood cancers, such as leukemia. That's why having a team of specialists with expertise focused specifically on pediatric sarcomas can make such a difference in the effectiveness of treatment. The University of Chicago Medicine Comer Children's Hospital offers a full range of treatment options, including promising new therapies that are available at only a few leading centers in North America, including hyperthermic intraperitoneal chemotherapy (HIPEC). Our participation in Children's Oncology Group (COG), an international research organization, gives our medical team -- and our patients -- access to clinical trials of new therapies that may be more effective than standard treatments. Some of our physicians serve as national study coordinators for COG trials.

Innovative Surgery for Bone Cancer, to Keep Kids Active as They Grow

Our orthopaedic surgeons are innovators in using surgical techniques that remove cancerous bone and tissue, sparing much of the child's healthy bone and tissue. Treatments are tailored to maximize normal growth and long-term limb function. It has become very rare for our surgeons to have to amputate a limb.

All Services and Specialists Under One Roof

From diagnosis through treatment and rehabilitation, all the services your child may need are right here at Comer Children's -- for convenient, comprehensive and coordinated care. Most importantly, we treat patients as a “team”. Pediatric oncologists, surgeons, orthopaedic oncologists, radiation oncologists, pathologists, cancer nurses and other team members meet together every week to address each child's needs.

Treating "Kids" of All Ages

Some cancers considered “pediatric” might develop or recur in young adults. Whether you're 5 or 25, it's still best to be treated by pediatric specialists for these forms of pediatric cancer. Physicians at Comer Children's extend treatment and clinical trials to patients in their 20s who have pediatric sarcomas.

Care for a Lifetime

Children facing cancer often have ongoing medical, emotional, social and developmental needs. Our doctors, nurses and other healthcare professionals recognize these issues and provide resources and tools to help patients and families cope and stay informed. Although most sarcoma patients are cured, some may face other complex health problems as they grow older. The University of Chicago Childhood Cancer Survivors Center is an integrated program aimed at the prevention and treatment of long-term health issues associated with cancer therapy.